Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-06-11CGTN: Education in China's fight against poverty: Leaving no one behind
2021-06-11Greencity Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
2021-06-10Yiren Digital Reports First Quarter 2021 Financial Results
2021-06-10Hailiang Education Group Inc. Announces Results of Annual General Meeting of Shareholders for Fiscal Year 2021
2021-06-09Powermat Technologies Announces Investment in Shenzhen China and Opens a New Chinese Office, to Increase the Expansion of Wireless Charging Technology in the Region
2021-06-09BEST Inc. Announces Unaudited First Quarter 2021 Financial Results
2021-06-08Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
2021-06-08TIAN RUIXIANG Holdings Ltd Announces Initial Closing of Follow-on Public Offering
2021-06-08PingPong Payments launches new PLN and SEK currency exchange services
2021-06-07Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
2021-06-07Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
2021-06-04Huawei and Temenos Announce Technology Partnership Agreement
2021-06-04Huawei Launches Lossless Ethernet Storage Network Solution NoF+ to Spark Digital Finance Innovation
2021-06-03Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood"
2021-06-03TIAN RUIXIANG Holdings Ltd Announces Pricing of Follow-on Public Offering
2021-06-03Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai
2021-06-02Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody
2021-06-02New Digital Intelligence Drive, New Finance
2021-06-01Cango Inc. Reports First Quarter 2021 Unaudited Financial Results
2021-06-01Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China

First　Previous　1 2 3 4 5　Next　Last　Total 2402 20/Page Page 1 of 121 Go To: